Although there are reports in models of PD using mice deficient in the Nlrp3 gene [22, 23] as well as other NLRP3 inhibitors [62], what distinguishes our findings is the use of an effective drug that is safe in humans [24–26]. The gene discussed is NLRP3; the disease is Parkinson disease.